|
Ephraim
Lansky, M.D. (Selected Publications)
- Lansky
E, Schubert S, Neeman I. Pharmacological and therapeutic
properties of pomegranate. I Symposium International
Sobre El Granado [First International Symposium on
the Pomegranate], Orihuela, Spain, 15-17 October,
1998.
PDF.
- Schubert
SY, Lansky EP, Neeman I: Antioxidant and eicosanoid
enzyme inhibition properties of pomegranate seed oil
and fermented juice flavonoids. J Ethnopharmacol 1999;66:11-17.
PDF. 
Abstract.
- Kim
ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A,
Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R,
Ramachandran C, Rabi T, Kaplan B, Lansky E.: Chemopreventive
and adjuvant therapeutic potential of pomegranate
(Punica granatum) for human breast cancer. Breast
Cancer Res Treat 2002; 71:203-217.
PDF.
Abstract.
- Hora
JJ, Maydew ER, Lansky, EP, Dwivedi C: Chemopreventive
effects of pomegranate seed oil on skin tumor development
in CD1 mice. J Med Food 2003; 6: 157-161.
PDF.
Abstract.
- Toi
M, Bando H, Ramachandran C, Melnick SJ, Imai A, Fife
RS, Carr RE, Oikawa T, Lansky EP Preliminary studies
on the anti-angiogenic potential of pomegranate fractions
in vitro and in vivo. Angiogenesis. 2003;6(2):121-8.
PDF.
Abstract.
- van
Elswijk DA, Schobel UP, Lansky EP, Irth H, van der
Greef J. Rapid dereplication of estrogenic compounds
in pomegranate (Punica granatum) using on-line biochemical
detection coupled to mass spectrometry. Phytochemistry
65: 233-241, 2004.
PDF.
Abstract.
-
Kawaii S, Lansky EP. Differentiation-Promoting Activity
of Pomegranate (Punica granatum) Fruit Extracts in
HL-60 Human Promyelocytic Leukemia Cells. J Med Food
7: 13-18, 2004.
PDF.
- Mehta R, Lansky EP. Breast cancer
chemopreventive properties of pomegranate (Punica
granatum) fruit extracts in a mouse mammary organ
culture. Eur J Cancer Prev. 2004; 13:345-8.
- Albrecht M, Jiang W, Kumi-Diaka J,
Lansky EP, Gommersall LM, Patel A, Mansel RE, Neeman
I, Geldof AA, Campbell MJ. Pomegranate extracts potently
suppress proliferation, xenograft growth, and invasion
of human prostate cancer cells. J Med Food. 2004;7:274-83.
- Lansky EP, Jiang W, Mo H, Bravo L,
Froom P, Yu W, Harris NM, Neeman I, Campbell MJ. Possible
synergistic prostate cancer suppression by anatomically
discrete pomegranate fractions. Invest New Drugs.
2005; 23:11-20.
- Lansky EP, Harrison G, Froom P, Jiang WG. Pomegranate
(Punica granatum) pure chemicals show possible synergistic
inhibition of human PC-3 prostate cancer cell invasion
across MatrigelTM. Invest New Drugs 2005; 23: 121-2.
- Lansky EP, von Hoff DD. Complex and simple. Leuk
Res. 2005 29: 601-2.
- Aslam MN, Lansky EP, Varani J. Pomegranate as a
cosmeceutical source: Pomegranate fractions promote
proliferation and procollagen synthesis and inhibit
matrix metalloproteinase-1 production in human skin
cells. J Ethnopharmacol. 2006: 103: 311-8.
- Lansky EP. Beware of pomegranates bearing 40% ellagic
Acid. J Med Food. 2006: 9: 119-22.
- Lansky, E.P. and Newman, R.A. Punica granatum (pomegranate)
and its potential for prevention and treatment of
inflammation and cancer. J Ethnopharmacol. 2007 109:
177-206.
|
|
|
